Current Members Aya Shibuya, Ph.D. Postdoctoral Fellow Inhibiting Nemo-like Kinase for Treatment of DBA January 13, 2021Read more
Current Members Minyoung Youn, Ph.D. Staff Research Scientist, Role of RSK in Normal Hematopoiesis and AML August 7, 2020Read more
Current Members Lucy Liu, Ph.D. Senior Scientist, NLK Inhibitors in Mouse Models of DBA August 7, 2020Read more
Current Members Mark Wilkes, Ph.D. Instructor Normal and Aberrant Erythropoiesis August 7, 2020Read more
Current Members Mark Smith, Ph.D. Medicinal Chemist, ChEM-H, Drug Development August 7, 2020Read more
Current Members Anna Wojcicki Medical Student, University of Minnesota School of Medicine, Niclosamide for Treatment of AML August 7, 2020Read more
Current Members Ryan Sathianathen Undergraduate Student, University of Pennsylvania, Regulation of p53 by Nemo-like Kinase August 7, 2020Read more
Current Members Kevin Jung Undergraduate Student, Stanford University, Targeting Nemo-like Kinase in Diamond Blackfan Anemia August 7, 2020Read more
Current Members Kailen Mark Life Science Research Professional, Mechanisms of drug resistance in AML August 7, 2020Read more
Current Members Mikhail Hameedi Structural Biology of CREB:CBP and identification of inhibitors August 7, 2020Read more